Navigation Links
Cimzia(R) (certolizumab pegol) Now Available for Self-Administration in Adult Patients With Moderate to Severe Crohn's Disease
Date:5/15/2009

ide and know when they have injected all of the medication. Additionally, the packaging utilizes Velcro(R) for easy opening and resealing.

In addition, the new Cimzia(R) prefilled syringe carries the Arthritis Foundation(R) Ease-of-Use Commendation. The Arthritis Foundation(R) created the program to encourage manufacturers to design user-friendly products and packaging. Manufacturers submit their products for testing by an independent lab experienced in the design and evaluation of products that are accessible to people with functional limitations due to the effects of arthritis.

Cimzia(R) was approved by the U.S. Food and Drug Administration on April 22, 2008 for reducing the signs and symptoms of moderate to severe Crohn's disease and maintaining clinical response in adult patients who have had an inadequate response to conventional therapy. The new prefilled syringe is now available to Crohn's patients taking Cimzia(R) for subcutaneous self-administration once every four weeks after initial doses once a physician has provided instruction for proper use.

The Crohn's approval was based on safety and efficacy data from clinical trials in more than 1,500 patients with Crohn's disease. Cimzia(R) was also recently approved in the U.S. for the treatment of adults with moderately to severely active rheumatoid arthritis.

About CIMZIA(R) (certolizumab pegol)

Cimzia(R) is the only PEGylated anti-TNF (Tumor Necrosis Factor). Cimzia(R) has a high affinity for human TNF-alpha, selectively neutralising the pathophysiological effects of TNF-alpha. Over the past decade, TNF-alpha has emerged as a major target of basic research and clinical investigation. This cytokine plays a key role in mediating pathological inflammation, and excess TNF-alpha production has been directly implicated in a wide variety of diseases. The U.S. Food and Drug Administration (FDA) ha
'/>"/>

SOURCE UCB
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Nektar Announces UCBs Cimzia(R) Approved by U.S. FDA for Adult Patients Suffering From Moderate to Severe Rheumatoid Arthritis
2. UCBs CIMZIA(R) (certolizumab pegol) Approved by the U.S. FDA for Adult Patients Suffering From Moderate to Severe Rheumatoid Arthritis
3. Newly-Approved Cimzia(R) Provides Rapid, Sustained Response in Crohns Patients
4. UCB Launches CIMplicity(TM) Program to Enhance Treatment Support for Cimzia(R) (certolizumab pegol) Patients and Caregivers
5. FDA Approval of Cimzia(R) for Crohns Disease Represents Latest Milestone for Nektars PEGylation Technology Platform
6. New Online Project Management Fundamentals for Healthcare Module Available
7. KT Tape: Secret Weapon of Elite Athletes - Now Available to Everyone
8. Fiber Technology Products that Help Combat Spread of Superbugs Now Available to the Consumer Market
9. Providence Service Corporation Makes Its Spring 2009 Presentation Publicly Available
10. New Once-Daily RYZOLT(TM) (tramadol HCl extended-release tablets) Now Available in the U.S.
11. Diatherix Laboratories Releases First Clinically Available Test For Confirmation of The Swine Flu Virus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... In this episode of SCI TV , ... her study that searched for commonalities in the stories ... Field. Shadle wanted to explore the key factors, beyond ... success and helped win the Olympic gold. The mental ... to peak athletic performance but to any major life ...
(Date:2/26/2015)... The report segments the European patient ... end user, accessory, and region. The medical beds ... European patient handling equipment market, by product. However, ... at the highest CAGR in the forecast period. ... , On the basis of type of ...
(Date:2/26/2015)... When Cosmetic Town launched in 2012, ... included, what will soon be, the cornerstone of work ... plethora of insight that will be accessible to the ... Team has maintained during its existence. Users have more ... treatments by visiting the Cosmetic Town Journal’s doctor’s page. ...
(Date:2/26/2015)... Nevada (PRWEB) February 26, 2015 Imagine a ... no showers or proper baths and there was no one ... world, that day was today. In 2015, more than 2.5 ... the developing world. , A new initiative led by ... dramatically reduce those numbers, focusing specifically on women – who ...
(Date:2/26/2015)... Wound Care Advantage (WCA), an ... executive team by adding three key members possessing many ... time two WCA team members were promoted to key ... founded in 2002 and is one of the few ... team believes that providing outstanding patient care is the ...
Breaking Medicine News(10 mins):Health News:Anne Shadle and Controlling the Olympic Moment on SCI TV 2Health News:Anne Shadle and Controlling the Olympic Moment on SCI TV 3Health News:European Patient Handling Equipment Market Hit to $5,150.2 Million by 2019 - New Resaerch Report by MarketsanMarkets 2Health News:European Patient Handling Equipment Market Hit to $5,150.2 Million by 2019 - New Resaerch Report by MarketsanMarkets 3Health News:Cosmetic Town has now Recreated Itself by Adding New Features 2Health News:DRI launches Global Initiative to Provide Women in Developing Countries with Clean Water 2Health News:DRI launches Global Initiative to Provide Women in Developing Countries with Clean Water 3Health News:Wound Center Management Leader WCA Expands Its Team to Include Additional Industry Experts 2Health News:Wound Center Management Leader WCA Expands Its Team to Include Additional Industry Experts 3Health News:Wound Center Management Leader WCA Expands Its Team to Include Additional Industry Experts 4
... clinical trial program has demonstrated the effectiveness and ... medicine for idiopathic pulmonary fibrosis, or IPF., In ... investigators discovered that the oral anti-fibrotic and anti-inflammatory ... capacity in patients suffering from IPF. , ...
... 2009, SAN DIEGOAutomated phone calling may help physicians solve ... for chronic health conditions., Researchers at the Kaiser Permanente ... automated calling service designed to encourage patients with asthma ... (ICS). , The research will be presented on ...
... in Forced Vital Capacity is among strongest predictors of ... (Nasdaq: ITMN ) today reported that results ... of clinical status and the risk of death in ... the 2009 International Conference of the American Thoracic Society ...
... being attacked , , SUNDAY, May 17 (HealthDay News) --They can ... unpredictable, warns the American College of Emergency Physicians (ACEP). , ... according to the U.S. Centers for Disease Control and Prevention. ... more than 31,000 people had to have reconstructive surgery as ...
... and excited to announce the introduction of Perma Facial ImplantsTM, a ... , ... Austin, Texas (PRWEB) -- Widner Oral & ... of Perma Facial ImplantTM, a safe definitive solution for permanent soft ...
... the University of Washington Medical Center led a group that ... the Seattle Police Department with a Taser over a six-year ... injury related to the restraint incident. No deaths occurred, even ... separate study led by Dr. Strote looked at every use ...
Cached Medicine News:Health News:Large clinical trial finds pirfenidone may help lung function in IPF patients 2Health News:Large clinical trial finds pirfenidone may help lung function in IPF patients 3Health News:Increasing ICS compliance: The voice may be recorded, but the results are real 2Health News:Increasing ICS compliance: The voice may be recorded, but the results are real 3Health News:Important Data Presented on Independent Predictors of Mortality in Patients With Idiopathic Pulmonary Fibrosis 2Health News:Important Data Presented on Independent Predictors of Mortality in Patients With Idiopathic Pulmonary Fibrosis 3Health News:Important Data Presented on Independent Predictors of Mortality in Patients With Idiopathic Pulmonary Fibrosis 4Health News:Important Data Presented on Independent Predictors of Mortality in Patients With Idiopathic Pulmonary Fibrosis 5Health News:Important Data Presented on Independent Predictors of Mortality in Patients With Idiopathic Pulmonary Fibrosis 6Health News:Beware of Dog Bites 2Health News:Widner Oral Surgery is the First Oral Surgery Practice in Austin to Offer Perma Facial ImplantsTM 2
(Date:2/26/2015)... NORTH CHICAGO, Ill. , Feb. 26, 2015 ... announced that 15 abstracts of studies in its ... for presentation during the 67 th American ... Washington, D.C. , from April 18-25. The ... FDA-approved product, DUOPA, in addition to investigational treatments ...
(Date:2/26/2015)... , Feb. 26, 2015  IRIDEX Corporation (NASDAQ: ... quarter and full year 2014 financial results after the market ... with the release, the Company will host a conference call ... on Thursday, March 5, 2015 to discuss ... Interested parties may access the live conference call via ...
(Date:2/26/2015)...  Mail-service and specialty pharmacies will save ... health plans $23.3 billion over the next decade, ... Management Association (PCMA). "Home delivery of ... easiest ways to reduce health costs," said PCMA ... should resist efforts to restrict these cost-saving tools." ...
Breaking Medicine Technology:AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 2AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 3AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 4AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 5AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 6AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 7IRIDEX Announces Fourth Quarter and Full Year 2014 Conference Call and Release Date 2PCMA: Report Shows High-Tech Specialty and Mail-Service Pharmacies Will Reduce Costs for Texas Employers, Consumers and Public Programs by $23.3 Billion 2
... MINNETONKA, Minn. , July 14 American ... provider of world-class devices and therapies for both male and ... study on their market leading MiniArc Single-Incision Sling System for ... MiniArc efficacy rates for negative cough stress test (CST) and ...
... and TULSA, Okla. , July 14 ... strategic alliance to increase the availability of important new ... These tests and the GeneMedRx medication management software can ... personalize their prescribing practices in order to prevent adverse ...
Cached Medicine Technology:12-Month Study Reports 90% Success Rate for AMS' MiniArc Single-Incision Sling 212-Month Study Reports 90% Success Rate for AMS' MiniArc Single-Incision Sling 3Helix Bioscience Appointed DNA Drug Sensitivity Testing Distributor for Genelex Corporation 2
The Medium External Fixator has a double-rod frame, medium Combination Clamp medium Multi-Pin Clamp, and Carbon Fiber Rods. Rod Attachment for Medium Multi-Pin Clamp allows second rod to be added....
... is a low osmolar ionic dimer. ... ioxaglate meglumine, 196 mg of ioxaglate ... calcium disodium as a stabilizer. The ... in each milliliter and provides 32% ...
... non-ionic monomeric contrast medium for intravascular and ... After a decade of clinical experience and ... has proven to be a valuable part ... radiology departments.Results from large multicentre monitoring trials1-3 ...
... liver-specific contrast agent approved for sale in ... expands the Amersham Health portfolio to include ... TESLASCAN aids in the detection, localization, characterization, ... begin within minutes of injection, and additional ...
Medicine Products: